Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
4(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
10%
Ph phase_1
6
60%
Ph phase_2
3
30%

Phase Distribution

6

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
6(60.0%)
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(6)

Detailed Status

Completed6
Recruiting4

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (60.0%)
Phase 23 (30.0%)
Phase 31 (10.0%)

Trials by Status

completed660%
recruiting440%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10